Skip to main navigation
Skip to search
Skip to main content
University of Hertfordshire (Research Profiles) Home
Home
Profiles
Research output
Projects
Research units
Search by expertise, name or affiliation
Stimulant and hallucinogenic novel psychoactive substances; an update
Fabrizio Schifano
, Alessandro Vento
, Norbert Scherbaum
, Amira Guirguis
Department of Clinical, Pharmaceutical and Biological Science
Centre for Health Services and Clinical Research
Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
School of Life and Medical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
20
Citations (Scopus)
120
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Stimulant and hallucinogenic novel psychoactive substances; an update'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Novel Psychoactive Substances
100%
Stimulants
100%
Psychedelics
100%
Phenethylamines
57%
Tryptamine
28%
Synthetic Cathinones
28%
Cabergoline
14%
Antagonist Activity
14%
Psychological Risk
14%
Lysergamides
14%
Computational Chemistry
14%
Dependence Liability
14%
Psychedelic Research
14%
Therapeutic Benefits
14%
Potential Therapeutics
14%
Methamphetamine
14%
Benzofuran
14%
Phencyclidine
14%
Ketamine
14%
Aminorex
14%
Aminoindane
14%
Medical Risk
14%
Website Analysis
14%
Phenmetrazine
14%
N-methyl-D-aspartate Receptor (NMDAR)
14%
Advanced Research
14%
Amphetamine
14%
Piperazine
14%
Integrative Model
14%
In Vivo Preclinical Studies
14%
Pseudoephedrine
14%
Synthetic Stimulants
14%
Prodrug
14%
5-HT Receptor Subtypes
14%
Pharmacology, Toxicology and Pharmaceutical Science
Psychotomimetic
100%
Phenethylamine Derivative
44%
Cathinone
22%
Receptor Subtype
11%
Ketamine
11%
N Methyl Dextro Aspartic Acid Receptor
11%
Phenmetrazine
11%
Preclinical Study
11%
Tryptamine Derivative
11%
Tryptamine
11%
Ergoline Derivative
11%
Prodrug
11%
Pseudoephedrine
11%
Amphetamine Derivative
11%
Aminorex
11%
Phencyclidine
11%
Benzofuran
11%
Piperazine Derivative
11%